Finance

Lists
SVE:WSE
Synthaverse SA
PLN 2,84
+1,79%
(+0,050) 1D
7 Okt., 17:00:00 GMT+2  ·   PLN
All symbols
SymbolPriceChange% Change
Generating top insights for SVE...
Open
PLN 2,79
High
PLN 2,90
Low
PLN 2,78
Mkt. cap
215,04 m
Avg. vol.
28,73 k
Volume
110,09 k
52-wk high
PLN 4,34
52-wk low
PLN 2,60
Shares outstanding
76,02 m
No. of employees
214
Open
PLN 2,79
High
PLN 2,90
Low
PLN 2,78
Mkt. cap
215,04 m
Avg. vol.
28,73 k
Volume
110,09 k
52-wk high
PLN 4,34
52-wk low
PLN 2,60
Shares outstanding
76,02 m
No. of employees
214
News stories
From web sources and news partners
Profile
Synthaverse S.A., formerly known as Biomed-Lublin Wytwórnia Surowic i Szczepionek is a Polish pharmaceutical company operating since 1944. The company manufactures medicinal preparations. The company's headquarters is in Lublin. Wikipedia
About Synthaverse SA
CEO-
Employees214
Founded1944
Headquarters-
Sector-
Websitesynthaverse.com
Previous reportsAll values in PLN
Loading Previous Earnings...
Revenue
Net income
All values in PLN
Sep. 2025
Des. 2025
Mrt. 2026
Jun. 2026
Revenue
4,79 m
17,51 m
13,61 m
12,85 m
Cost of goods sold
3,12 m
8,05 m
6,43 m
5,40 m
Cost of revenue
3,12 m
8,05 m
6,43 m
5,40 m
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
8,38 m
10,86 m
10,25 m
11,29 m
Operating expense
9,07 m
17,01 m
7,88 m
8,09 m
Total operating expenses
12,20 m
25,06 m
14,31 m
13,49 m
Operating income
-7,41 m
-7,55 m
-701,00 k
-641,00 k
Other non operating income
-357,00 k
64,00 k
-
-1,00 k
EBT including unusual items
-8,96 m
-8,71 m
-4,14 m
-3,42 m
EBT excluding unusual items
-8,96 m
-8,46 m
-4,18 m
-3,38 m
Income tax expense
-1,24 m
-1,80 m
-537,00 k
-656,00 k
Effective tax rate
13,78%
20,72%
12,96%
19,20%
Other operating expenses
689,00 k
6,15 m
-2,37 m
-3,20 m
Net income
-7,72 m
-6,90 m
-3,61 m
-2,76 m
Net profit margin
-161,27%
-39,43%
-26,50%
-21,48%
Earnings per share
-
-
-
-
Interest and investment income
-
535,00 k
-
-
Interest expense
-1,20 m
-1,49 m
-2,58 m
-3,63 m
Net interest expenses
-1,20 m
-956,00 k
-2,58 m
-3,63 m
Depreciation and amortization charges
-
-
-
-
EBITDA
-4,20 m
-5,56 m
2,67 m
2,74 m
Gain or loss from assets sale
-
-250,00 k
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google-programme